Friday November 27 2009 | Biotechnology feed | All feeds
|
|
Eukarion Incorporated
Download detailed PDF Members: Eukarion's protein modification program is directed at blocking the function of intracellular disease-associated targets using modified LipoclonalŪ antibodies. The modification enables their passage across blood vessel walls and cellular membranes and, thus, their entry into cells to block their selected target.
This page has been viewed 375 times since April 2007, the link to the organisation's website has been followed 87 times Recent Search Terms used to find this page: Eukarion | . Search for more companies in Bedford Search for more companies in MA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Eukarion Incorporated | ||||||||||||||||||||||||||||||||||||||
|